Skip to main content

Publisher: Wiley-Blackwell

Volume 29, Number 12, 1 December 2012

Inpatient electronic prescribing data can be used to identify ‘lost’ discharge codes for diabetes
pp. e430-e435(6)
Authors: Nirantharakumar, K.; Marshall, T.; Hemming, K.; Narendran, P.; Coleman, J. J.

Favourites:
ADD

Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus
pp. e436-e439(4)
Authors: Dereke, J.; Nilsson, C.; Landin‐Olsson, M.; Hillman, M.

Favourites:
ADD

The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients
pp. e440-e444(5)
Authors: Øzbay, L. A.; Møller, N.; Juhl, C.; Bjerre, M.; Carstens, J.; Rungby, J.; Jørgensen, K. A.

Favourites:
ADD

Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized
pp. e445-e448(4)
Authors: Nirantharakumar, K.; Marshall, T.; Kennedy, A.; Narendran, P.; Hemming, K.; Coleman, J. J.

Favourites:
ADD

Vibration thresholds are increased at low frequencies in the sole of the foot in diabetes—a novel multi‐frequency approach
pp. e449-e456(8)
Authors: Nelander, J.; Speidel, T.; Björkman, A.; Dahlin, L. B.

Favourites:
ADD

Elevated 1‐h plasma glucose following 75‐g oral glucose load is a predictor of arterial stiffness in subjects with normal glucose tolerance
pp. e457-e460(4)
Authors: Niijima, K.; Muranaka, Y.; Ando, T.; Okada, S.; Niijima, Y.; Hashimoto, K.; Yamada, M.; Ohshima, K.; Mori, M.; Ono, K.

Favourites:
ADD

Patients’ intentions to inform relatives about Type 2 diabetes risk: the role of worry in the process of family risk disclosure
pp. e461-e467(7)
Authors: Esch, S. C. M.; Nijkamp, M. D.; Cornel, M. C.; Snoek, F. J.

Favourites:
ADD

The tuning fork and the at‐risk foot
pp. 1477-1477(1)
Author: Hitman, Graham A.

Favourites:
ADD

Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta‐analysis
pp. 1480-1492(13)
Authors: Ranasinghe, P.; Jayawardana, R.; Galappaththy, P.; Constantine, G. R.; de Vas Gunawardana, N.; Katulanda, P.

Favourites:
ADD
Favourites:
ADD

Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross‐sectional population‐based study
pp. 1501-1505(5)
Authors: Hellgren, M. I.; Petzold, M.; Björkelund, C.; Wedel, H.; Jansson, P.‐A.; Lindblad, U.

Favourites:
ADD

Prevalence of ketoacidosis at diagnosis of childhood onset Type 1 diabetes in Wales from 1991 to 2009 and effect of a publicity campaign
pp. 1506-1509(4)
Authors: Lansdown, A. J.; Barton, J.; Warner, J.; Williams, D.; Gregory, J. W.; Harvey, J. N.; Lowes, L.; on behalf of the Brecon Groupcr8

Favourites:
ADD
Favourites:
ADD

Exenatide plus metformin compared with metformin alone on β‐cell function in patients with Type 2 diabetes
pp. 1515-1523(9)
Authors: Derosa, G.; Franzetti, I. G.; Querci, F.; Carbone, A.; Ciccarelli, L.; Piccinni, M. N.; Fogari, E.; Maffioli, P.

Favourites:
ADD

Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high‐risk population
pp. 1524-1528(5)
Authors: Juurlink, D. N.; Gomes, T.; Shah, B. R.; Mamdani, M. M.

Favourites:
ADD

Offloading effect of therapeutic footwear in patients with diabetic neuropathy at high risk for plantar foot ulceration
pp. 1534-1541(8)
Authors: Arts, M. L. J.; Waaijman, R.; de Haart, M.; Keukenkamp, R.; Nollet, F.; Bus, S. A.

Favourites:
ADD

Pressure‐reduction and preservation in custom‐made footwear of patients with diabetes and a history of plantar ulceration
pp. 1542-1549(8)
Authors: Waaijman, R.; Arts, M. L. J.; Haspels, R.; Busch‐Westbroek, T. E.; Nollet, F.; Bus, S. A.

Favourites:
ADD

A pocket‐sized disposable device for testing the integrity of sensation in the outpatient setting
pp. 1550-1552(3)
Authors: Bowling, F. L.; Abbott, C. A.; Harris, W. E.; Atanasov, S.; Malik, R. A.; Boulton, A. J. M.

Favourites:
ADD

Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes
pp. 1553-1555(3)
Authors: Bracewell, N.; Game, F.; Jeffcoate, W.; Scammell, B. E.

Favourites:
ADD

Skin autofluorescence and risk of micro‐ and macrovascular complications in patients with Type 2 diabetes mellitus—a multi‐centre study
pp. 1556-1561(6)
Authors: Noordzij, M. J.; Mulder, D. J.; Oomen, P. H. N.; Brouwer, T.; Jager, J.; Castro Cabezas, M.; Lefrandt, J. D.; Smit, A. J.

Favourites:
ADD

Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type 2 diabetes
pp. 1562-1566(5)
Authors: Rodríguez‐Segade, S.; Rodríguez, J.; García López, J. M.; Casanueva, F. F.; Camiña, F.

Favourites:
ADD

The risk of proliferative retinopathy in siblings with Type 1 diabetes
pp. 1567-1573(7)
Authors: Hietala, K.; Forsblom, C.; Summanen, P.; Groop, P.‐H.; on behalf of the FinnDiane Study Groupcr5

Favourites:
ADD

Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program
pp. 1579-1588(10)
Authors: Mather, K. J.; Christophi, C. A.; Jablonski, K. A.; Knowler, W. C.; Goldberg, R. B.; Kahn, S. E.; Spector, T.; Dastani, Z.; Waterworth, D.; Richards, J. B.; Funahashi, T.; Pi‐Sunyer, F. X.; Pollin, T. I.; Florez, J. C.; Franks, P. W.; for the Diabetes Prevention Program Research Groupcr16

Favourites:
ADD

INPPL1 is associated with the metabolic syndrome in men with Type 1 diabetes, but not with diabetic nephropathy
pp. 1589-1595(7)
Authors: Hyvönen, M. E.; Ihalmo, P.; Forsblom, C.; Thorn, L.; Sandholm, N.; Lehtonen, S.; Groop, P.‐H.

Favourites:
ADD
Favourites:
ADD

How to reduce the risk of failing to reach recruitment targets: lessons learnt from a pump pilot trial
pp. 1600-1601(2)
Authors: Barnard, K. D.; Campbell, M. J.; Emery, C.; Young, A. J.; Heller, S.

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more